Cargando…
Fundamental considerations in drug design
The drug discovery paradigm has been very time-consuming, challenging, and expensive; however, the disease conditions originating from bacteria, virus, protozoa, fungus and other microorganisms are steadily shooting up. For instance, COVID-19 is the latest viral infection that affects millions of pe...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212230/ http://dx.doi.org/10.1016/B978-0-323-90608-1.00005-8 |
_version_ | 1784730533946720256 |
---|---|
author | Mahapatra, Manoj Kumar Karuppasamy, Muthukumar |
author_facet | Mahapatra, Manoj Kumar Karuppasamy, Muthukumar |
author_sort | Mahapatra, Manoj Kumar |
collection | PubMed |
description | The drug discovery paradigm has been very time-consuming, challenging, and expensive; however, the disease conditions originating from bacteria, virus, protozoa, fungus and other microorganisms are steadily shooting up. For instance, COVID-19 is the latest viral infection that affects millions of people and the world’s economy very severely. Therefore, the quest for discovery of novel and potent drug compounds against deadly pathogens is crucial at the moment. Despite a lot of drawbacks in drug discovery and development and its pertaining technology, the advancement must be taken into account so the time duration and cost would be minimized. In this chapter, basic principles in drug design and discovery have been discussed together with advances in drug development. |
format | Online Article Text |
id | pubmed-9212230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-92122302022-06-22 Fundamental considerations in drug design Mahapatra, Manoj Kumar Karuppasamy, Muthukumar Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches Article The drug discovery paradigm has been very time-consuming, challenging, and expensive; however, the disease conditions originating from bacteria, virus, protozoa, fungus and other microorganisms are steadily shooting up. For instance, COVID-19 is the latest viral infection that affects millions of people and the world’s economy very severely. Therefore, the quest for discovery of novel and potent drug compounds against deadly pathogens is crucial at the moment. Despite a lot of drawbacks in drug discovery and development and its pertaining technology, the advancement must be taken into account so the time duration and cost would be minimized. In this chapter, basic principles in drug design and discovery have been discussed together with advances in drug development. 2022 2022-06-17 /pmc/articles/PMC9212230/ http://dx.doi.org/10.1016/B978-0-323-90608-1.00005-8 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mahapatra, Manoj Kumar Karuppasamy, Muthukumar Fundamental considerations in drug design |
title | Fundamental considerations in drug design |
title_full | Fundamental considerations in drug design |
title_fullStr | Fundamental considerations in drug design |
title_full_unstemmed | Fundamental considerations in drug design |
title_short | Fundamental considerations in drug design |
title_sort | fundamental considerations in drug design |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212230/ http://dx.doi.org/10.1016/B978-0-323-90608-1.00005-8 |
work_keys_str_mv | AT mahapatramanojkumar fundamentalconsiderationsindrugdesign AT karuppasamymuthukumar fundamentalconsiderationsindrugdesign |